Type of hormone therapy may determine whether trans men continue to menstruate - Insights on Science, Law, and Technology Transfer

Type of Hormone Therapy Influences Menstruation in Trans Men

A recent study published in Science has revealed that the type of hormone therapy administered to trans men significantly impacts whether they continue to experience menstruation. The research indicates that those using gel or cream formulations are 10 times more likely to retain their menstrual cycles compared to individuals on injectable testosterone therapies. This finding raises important considerations for both medical practitioners and patients navigating hormone treatment options.

The study's authors noted that while testosterone therapy is intended to suppress menstruation, the method of administration plays a pivotal role in its effectiveness. Trans men using topical gels or creams may experience less suppression of menstrual cycles due to the way these hormones are absorbed into the body. This can lead to varying experiences among individuals, making it crucial for healthcare providers to tailor hormone therapy based on personal needs and preferences.

This research not only sheds light on the physiological effects of different hormone therapies but also emphasizes the importance of informed decision-making in the trans community. Understanding the potential outcomes of various hormone treatments can empower trans men to choose options that align with their health goals. As discussions around gender-affirming care continue to evolve, insights like these are vital in fostering a more personalized and effective approach to hormone therapy.

For more details, you can read the full article on Science.

Comments